No recommendation
No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.
(Sharecast News) - The Financial Mail on Sunday's Midas column labelled shares of Oxford Instruments a "long-term buy".
First, the company's kit was helping in the discovery of new drugs and to make scientific discoveries.
Midas also called attention to Oxford's specialisation on cryostats, the tools that allow manufacturers to drive temperatures down to as cold as in outer space.
Those would be key for quantum computing, an industry that by 2035 was seen reaching 1trn in value, it said.
Furthermore, the company's new boss, Richard Tyson, was determined to make his mark and had just unveiled a new strategy.
Over the year to March, revenues jumped 10% to 470m and profit by 2% to 83m
Not surprisingly, brokers were expecting growth in sales to 520m and in profit to 90m by 2026, together with a higher dividend.
The value of investments can go down in value as well as up, so you could get back less than you invest. It is therefore important that you understand the risks and commitments. This website is not personal advice based on your circumstances. So you can make informed decisions for yourself we aim to provide you with the best information, best service and best prices. If you are unsure about the suitability of an investment please contact us for advice.
